Chlamydophila pneumoniae specific antibodies in Thai patients with myocardial infarction
Piyada Wangroongsarb1, Puchaniyada Phuekfen, Pimjai Naigowit
1National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand. piyada@dmsc.moph.go.th
Insights
This study explored the link between Chlamydia pneumoniae infection and acute myocardial infarction (AMI). While prevalence rates were similar, higher IgG antibody titers in AMI patients suggest a potential association.
Area of Science:
- Infectious Diseases
- Cardiology
- Immunology
Background:
- Chlamydia pneumoniae is a potential etiological agent in cardiovascular diseases.
- Understanding its role in acute myocardial infarction (AMI) is crucial for public health.
Purpose of the Study:
- To investigate the correlation between Chlamydia pneumoniae infection and acute myocardial infarction (AMI).
- To assess the prevalence and antibody titers of C. pneumoniae in AMI patients compared to healthy controls.
Main Methods:
- Micro-immunofluorescence test was used to analyze serum specimens from 101 AMI patients and healthy blood donors.
- Serologic tests measured Chlamydia pneumoniae antibody-positive cases and IgG/IgM titers.
Main Results:
- 52% of AMI patients were positive for C. pneumoniae antibodies, with no significant difference in prevalence compared to controls.
- Elevated IgG antibody titers were observed in AMI patients, suggesting a possible association.
- Evidence of current infection was noted in some AMI patients based on significant titer increases or specific IgM levels.
Conclusions:
- Higher IgG titers in AMI patients may indicate an association between Chlamydia pneumoniae infection and acute myocardial infarction.
- No significant correlation was found between serologic results and traditional cardiovascular risk factors like diabetes or hypertension.
Abstract:
To investigate the correlation between Chlamydia pneumoniae infection and acute myocardial infarction (AMI), a total of 101 serum specimens collected from patients with AMI admitted to the coronary care unit, Bhumibol Adulyadej Hospital, and serum specimens collected from healthy blood donors (control group) were examined by using the micro-immunofluorescence test. C. pneumoniae antibody-positive cases were found in 52 (52%) patients, consisting of 30 males and 22 females, though no significant difference of prevalence rate was observed when compared with the rate in the control group. However, the level of IgG titers in patients was higher than that in the controls, and this finding may support an association between C. pneumoniae infection and AMI. Among patients with AMI, several cases were suspected to have current infections because of a fourfold or higher titer increase in IgG or titers in IgM antibody of 1:32 or 1:64. There is no significant correlation between serologic test results and diabetes mellitus, hypertension, hyper cholesterol, a smoking habit, or the location of myocardial infarction among patients with AMI.
More Related Videos
12:09Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Pneumonia III: Complications and Assessment
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Atypical Pneumonia
